The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials.

Autor: Farhadfar N; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida., Ahn KW; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Bo-Subait S; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, Minnesota., Logan B; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Stefanski HE; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, Minnesota., Hsu JW; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida., Panch S; NIH-Experimental Transplantation and Immunology Branch, National Cancer Institute - NIH, NIH Clinical Center, Department of Transfusion Medicine, Bethesda, Maryland., Confer D; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, Minnesota., Liu H; H. Lee Moffitt Cancer and Research Center, Tampa, Florida., Badawy SM; Division of Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, Florida., Diaz MA; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain., Hildebrandt GC; Markey Cancer Center, University of Kentucky, Lexington, Kentucky., Kelkar AH; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Lazarus HM; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio., Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida., Preussler JM; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, Minnesota., Schears RM; Department of Emergency Medicine, University of Central Florida, Orlando, Florida., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., van der Poel M; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands., Bruce JG; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Pulsipher MA; Division of Hematology and Oncology, Intermountain Primary Children's Medical Center, Huntsman Cancer Institute at the Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah., Shaw BE; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: beshaw@mcw.edu., Wingard JR; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida., Switzer GE; Departments of Medicine, Psychiatry, and Clinical and Translational Science, University of Pittsburgh, Pittsburgh, Pennsylvania.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2022 Sep; Vol. 28 (9), pp. 603.e1-603.e7. Date of Electronic Publication: 2022 Jun 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Unrelated hematopoietic stem cell donors as research subjects.

Autor: King, R. J.¹, Confer, D. L.¹, Greinix, H. T.², Halter, J.³, Horowitz, M.⁴, Schmidt, A. H.⁵, Costeas, P.⁶, Shaw, B.⁷, Egeland, T.⁸

Publikováno v: Bone Marrow Transplantation. Jan2011, Vol. 46 Issue 1, p10-13. 4p. 1 Diagram.

Inorganic-Based Nanoparticles and Biomaterials as Biocompatible Scaffolds for Regenerative Medicine and Tissue Engineering: Current Advances and Trends of Development.

Autor: Saikia, Nabanita¹ (AUTHOR) nsaikia@nmhu.edu

Publikováno v: Inorganics. Nov2024, Vol. 12 Issue 11, p292. 39p.

Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.

Autor: Shah NN; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Schneiderman J; Pediatric Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Kuruvilla D; Clinical Pharmacology and Safety Sciences, AstraZeneca, San Francisco, California., Bhojwani D; Pediatric Hematology-Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California., Fry TJ; Pediatric Oncology, Children's Hospital Colorado, Denver, Colorado., Martin PL; Pediatric Oncology, Duke University Medical Center, Durham, North Carolina., Schultz KR; Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada., Silverman LB; Pediatric Hematology and Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts., Whitlock JA; Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada., Wood B; Department of Pathology, University of Washington, Seattle, Washington., Vainshtein I; Clinical Pharmacology and Safety Sciences, AstraZeneca, San Francisco, California., Adams A; National Marrow Donor Program/Be the Match, Minneapolis, Minnesota., Confer D; National Marrow Donor Program/Be the Match, Minneapolis, Minnesota.; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota., Pulsipher MA; Pediatric Hematology-Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California., Chaudhury S; Pediatric Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Wayne AS; Pediatric Hematology-Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Jan; Vol. 68 (1), pp. e28574. Date of Electronic Publication: 2020 Sep 22.